人民财讯8月23日电，据东软集团（600718）消息，近日，东软集团与武汉大学中南医院共同签署战略 合作协议。双方将围绕智慧医院建设、数字孪生应用、医工科研转化等核心领域，开启战略合作。 ...

Group 1 - The core point of the article is that Neusoft Corporation has won a bid for the procurement of organ transplantation and other medical service pricing project information system renovation for Dongying Central Hospital [1][2] - The bid was announced on August 20, 2025, and is part of a single-source procurement process [2] - Neusoft Corporation has made significant investments, with a total of 102 companies and participation in 43,128 bidding projects [1] Group 2 - Neusoft Corporation holds a substantial amount of intellectual property, including 428 trademark registrations, 2,246 patents, and 2,677 copyrights [1] - The company has also obtained 67 administrative licenses, indicating a strong regulatory compliance framework [1]

Group 1 - The stock price of Neusoft Corporation increased by 2.30% on August 22, reaching 10.67 CNY per share, with a total market capitalization of 12.689 billion CNY [1] - Year-to-date, Neusoft's stock price has risen by 0.47%, with a 5-day increase of 5.64%, a 20-day increase of 6.70%, and a 60-day increase of 10.11% [1] - As of March 31, 2025, Neusoft had 100,100 shareholders, an increase of 21.28% from the previous period, with an average of 12,025 circulating shares per shareholder, a decrease of 17.55% [2] Group 2 - For the first quarter of 2025, Neusoft reported revenue of 1.850 billion CNY, a year-on-year increase of 1.06% [2] - Neusoft has distributed a total of 1.894 billion CNY in dividends since its A-share listing, with 332 million CNY distributed over the past three years [2] - The top ten circulating shareholders of Neusoft include Hong Kong Central Clearing Limited, which holds 45.7619 million shares, a decrease of 15.8491 million shares from the previous period [2]

Core Viewpoint - Neusoft Corporation's stock price closed at 10.43 yuan on August 21, 2025, reflecting a decrease of 0.57% from the previous trading day, with a trading volume of 331,590 hands and a transaction amount of 347 million yuan [1] Company Overview - Neusoft Corporation specializes in information technology solutions, with business areas including healthcare informationization, smart cities, and enterprise digital transformation [1] - The company has made significant progress in AI applications and data monetization [1] Strategic Developments - Neusoft Corporation signed a strategic cooperation agreement with the Guizhou Provincial Big Data Development Administration, focusing on data industry ecosystem cultivation, digital transformation in healthcare, and smart medical technology breakthroughs and results transformation [1] - The collaboration aims to promote the monetization of medical data in Guizhou Province and establish a medical big data system based on the urban healthcare service platform [1] Financial Insights - On August 21, 2025, the net outflow of main funds was 20.98 million yuan, while the net inflow over the past five days was 11.44 million yuan [1]

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 采购方：南宁市医疗保障事业管理中心 供应商：东软集团股份有限公司 中标金额：458000.0 地区：广西壮族自治区 发布日期：2025-08-18 证券之星消息，根据天眼查APP-财产线索数据整理，根据南宁市医疗保障事业管理中心月8日18发布的 《广西科文招标有限公司关于南宁市医保基金核查和监管第三方服务外包项目（NNZC2025-G3-990748- KWZB）的中标公告》内容显示，东软集团股份有限公司中标，详情如下： 标题：广西科文招标有限公司关于南宁市医保基金核查和监管第三方服务外包项目（NNZC2025-G3- 990748-KWZB）的中标公告 通过天眼查大数据分析，东软集团股份有限公司共对外投资了101家企业，参与招投标项目43072次；财 产线索方面有商标信息428条，专利信息2246条，著作权信息2677条；此外企业还拥有行政许可69个。 数据来源：天眼查APP ...

Core Insights - The Chinese AI + medical imaging industry is rapidly developing, with a market size projected to reach 7.6 billion yuan in 2024, representing a year-on-year growth of 109.94% [1][11] - AI technology is capable of quickly identifying small lesions from vast amounts of imaging data, facilitating precise early screening for various diseases and providing significant diagnostic support for doctors [1][11] - The product types in AI medical imaging are diversifying, with a trend towards integrated hardware and software solutions becoming the preferred choice for medical institutions [1][11] Industry Overview - AI + medical imaging refers to the use of AI technologies, such as deep learning and computer vision, to analyze and process medical images (e.g., X-rays, CT scans, MRIs, ultrasounds) to assist doctors in disease diagnosis, treatment planning, and prognosis evaluation [1][4] - The core function includes auxiliary diagnosis, treatment planning, prognosis assessment, and early detection screening [1][4] Industry Value Chain - The upstream of the AI + medical imaging industry includes medical imaging equipment, chips, servers, storage devices, imaging acquisition and processing software, cloud services, network operation platforms, and algorithm and data platforms [4] - The midstream involves the development and manufacturing of AI + medical imaging technologies, while the downstream primarily serves medical institutions, health check centers, and research and educational institutions [4] Market Size - The market size of the Chinese medical imaging equipment industry is expected to reach 69.3 billion yuan in 2024, with a year-on-year growth of 9.83% [6] Relevant Policies - The Chinese government has issued several policy documents to support and regulate the development of the AI + medical imaging industry, emphasizing the optimization of medical device standards and the establishment of standardization organizations for AI and medical robotics [8][10] - The policies aim to accelerate approval processes, enhance innovation ecosystems, and improve international competitiveness [8][10] Key Companies and Performance - Major companies in the AI + medical imaging sector include United Imaging Healthcare, Wandong Medical, Mindray, and Shukun Technology, each leveraging unique strengths in hardware and AI software integration [13][15] - United Imaging Healthcare reported a revenue of 10.3 billion yuan in 2024, a decrease of 9.73% year-on-year, while its R&D investment increased by 17.84% to 2.261 billion yuan [15] - Shukun Technology focuses on providing comprehensive AI solutions for medical institutions, achieving significant market penetration with its innovative products [17] Industry Development Trends 1. The industry is expected to advance towards multi-modal data integration and deep learning, enhancing diagnostic accuracy and personalized treatment [20] 2. Applications of AI in medical imaging will expand from auxiliary diagnosis to full-process management, improving service efficiency and quality [21] 3. Regulatory frameworks will evolve to include data privacy protections and accountability mechanisms for AI-generated content [22]

东软集团最新股价为10.49元，较前一交易日上涨1.84%。当日开盘价为10.28元，最高触及10.49元，最 低下探至10.15元，成交量为35.66万手，成交金额达3.67亿元。 东软集团是国内首家上市的软件企业，主营业务涵盖医疗健康及社会保障、智慧城市、智能汽车互联等 领域。公司成立于1991年，总部位于辽宁沈阳。 根据公司公告，东软集团在回复上交所2024年年报问询函时披露，创新业务公司2024年对净利润的负向 影响合计达3.58亿元。公司医疗健康及社会保障业务2024年营收同比下降12.08%，智慧城市业务收入增 长49.95%主要依赖沈阳地铁等大项目集中验收。此外，公司2024年研发投入同比下降13.50%，研发人 员数量减少13.45%。 数据显示，东软集团当日主力资金净流入4879.56万元，近五日主力资金累计净流入2179.19万元。 风险提示：投资有风险，入市需谨慎。 来源：金融界 ...

Core Viewpoint - Neusoft (Guizhou) Intelligent Technology Co., Ltd. has been established with a registered capital of 50 million RMB, fully owned by Neusoft Group Co., Ltd. [1] Company Summary - The legal representative of Neusoft (Guizhou) Intelligent Technology Co., Ltd. is Luo Tengfei [1] - The company is registered with a capital of 50 million RMB [1] - Neusoft Group Co., Ltd. holds 100% of the shares [1] - The company operates in the software and information technology services industry, specifically focusing on software development and related services [1] Business Scope - The business scope includes software development, software sales, artificial intelligence application software development, computer system services, information system integration services, information technology consulting services, network and information security software development, information system operation and maintenance services, data processing and storage support services, digital technology services, and various technical services [1] - The company is also involved in the retail and wholesale of computer hardware and software, as well as intelligent control system integration [1] - The business activities are conducted in accordance with relevant laws and regulations, with the ability to operate autonomously unless specific approvals are required [1] Registration Details - The company is located at No. 2, 11th Floor, Unit 1, Defu Center, 357 Qianling Mountain Road, Changling Street, Guiyang High-tech Zone, Guizhou Province [1] - It is classified as a limited liability company (non-natural person investment or holding) [1] - The business registration is valid until August 18, 2025, with no fixed term thereafter [1] - The registration authority is the Guiyang National High-tech Industrial Development Zone Administrative Approval Bureau [1]

人民财讯8月19日电，企查查APP显示，近日，东软(贵州)数智技术有限公司成立，注册资本5000万元， 经营范围包含：人工智能应用软件开发；信息系统集成服务；信息技术咨询服务；网络与信息安全软件 开发等。企查查股权穿透显示，该公司由东软集团（600718）全资持股。 ...

Group 1 - Neusoft Group has established a new subsidiary named Neusoft (Guizhou) Intelligent Technology Co., Ltd. with a registered capital of 50 million yuan [1] - The business scope of the new company includes artificial intelligence application software development, information system integration services, information technology consulting services, and network and information security software development [1] - Neusoft Group holds 100% ownership of the newly established company [1]